Is there a situation where you would use a purine analogue in combination with rituximab for the frontline line treatment of normal variant Hairy Cell Leukemia?
Could one make a case for addition of Rituxinab frontline to increase the chances of a complete remission and even maybe achieve MRD-negative status ?
Answer from: Medical Oncologist at Academic Institution
This is an excellent question, and I was assisted in this answer by Drs. @Michael R. Grever and @Kerry A. Rogers who are both hairy cell leukemia experts since there is really not a lot of trial data to guide this answer. There is limited data for the addition of rituximab in the frontline set...
Sign in or Register to read more